Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply

por Oronsky, Bryan, Larson, Christopher, Caroen, Scott, Reid, Tony R.
Publicado 2022

What's New in SCLC? A Review

por Oronsky, Bryan, Reid, Tony R., Oronsky, Arnold, Carter, Corey A.
Publicado 2017

Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer

por Oronsky, Bryan, Larson, Chris, Reid, Tony R., Carter, Corey A.
Publicado 2018

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine

por Oronsky, Bryan, Gruber, Harry E., Reiners, Wendy, Reid, Tony R.
Publicado 2021

Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19

por Oronsky, Bryan., Knox, Susan., Cabrales, Pedro., Oronsky, Arnold., Reid, Tony R.
Publicado 2020

A Review of Newly Diagnosed Glioblastoma

por Oronsky, Bryan, Reid, Tony R., Oronsky, Arnold, Sandhu, Navjot, Knox, Susan J.
Publicado 2021

Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells

por Oronsky, Bryan, Reid, Tony R., Oronsky, Arnold, Caroen, Scott, Carter, Corey A., Cabrales, Pedro
Publicado 2018

Extended treatment with MY-NEOVAX, personalized neoantigen-enhanced oncolytic viruses, for two end-stage cancer patients

por Bouvet, Michael, Reid, Tony R, Larson, Chris, Oronsky, Bryan, Carter, Corey, Morris, John C
Publicado 2019

 RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"

por Oronsky, Bryan, Carter, Corey A., Caroen, Scott, Scribner, Curtis, Oronsky, Arnold, Reid, Tony R.
Publicado 2020

Going viral: a review of replication-selective oncolytic adenoviruses

por Larson, Christopher, Oronsky, Bryan, Scicinski, Jan, Fanger, Gary R., Stirn, Meaghan, Oronsky, Arnold, Reid, Tony R.
Publicado 2015

A Review of Persistent Post-COVID Syndrome (PPCS)

por Oronsky, Bryan, Larson, Christopher, Hammond, Terese C., Oronsky, Arnold, Kesari, Santosh, Lybeck, Michelle, Reid, Tony R.
Publicado 2021

Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets

por Carter, Corey A., Oronsky, Bryan, Caroen, Scott, Scicinski, Jan, Degesys, Aiste, Cabrales, Pedro, Reid, Tony R., Brzezniak, Christina
Publicado 2016

Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review

por Oronsky, Bryan, Ma, Patrick, Reid, Tony R., Cabrales, Pedro, Lybeck, Michelle, Oronsky, Arnold, Oronsky, Neil, Carter, Corey A.
Publicado 2017

Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management

por Oronsky, Bryan, Caroen, Scott, Oronsky, Arnold, Dobalian, Vaughn E., Oronsky, Neil, Lybeck, Michelle, Reid, Tony R., Carter, Corey A.
Publicado 2017

Data Management 101 for drug developers: A peek behind the curtain

por Oronsky, Bryan, Burbano, Erica, Stirn, Meaghan, Brechlin, Joanne, Abrouk, Nacer, Caroen, Scott, Coyle, Angelique, Williams, Jeannie, Cabrales, Pedro, Reid, Tony R.
Publicado 2023

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance

por Oronsky, Bryan, Carter, Corey A., Reid, Tony R., Scicinski, Jan, Oronsky, Arnold, Lybeck, Michelle, Caroen, Scott, Stirn, Meaghan, Oronsky, Neil, Langecker, Peter
Publicado 2015

Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001

por Hammond, Terese Catherine, Lee, Raymond C, Oronsky, Bryan, Reid, Tony R, Caroen, Scott, Juarez, Tiffany M, Gill, Jaya, Heng, Annie, Kesari, Santosh
Publicado 2022

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical be...

por Tomita, Yusuke, Oronsky, Bryan, Abrouk, Nacer, Cabrales, Pedro, Reid, Tony R., Lee, Min-Jung, Yuno, Akira, Baker, Jonathan, Lee, Sunmin, Trepel, Jane B.
Publicado 2021

No patient left behind: The promise of immune priming with epigenetic agents

por Carter, Corey A., Oronsky, Bryan T., Roswarski, Joseph, Oronsky, Arnold L., Oronsky, Neil, Scicinski, Jan, Lybeck, Harry, Kim, Michelle M., Lybeck, Michelle, Reid, Tony R.
Publicado 2017

Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001

por Carter, Corey A., Schmitz, Bruno, Peterson, P. Gabriel, Quinn, Mary, Degesys, Aiste, Jenkins, John, Oronsky, Bryan, Scicinski, Jan, Caroen, Scott, Reid, Tony R., Cabrales, Pedro, Brzezniak, Christina
Publicado 2016